LATEST PSYCHEDELICS STOCKS NEWS

1 views5 min read

Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19

Revive Therapeutics
TORONTO, March 25, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV), a life sciences company focused on the research and development of therapeutics for rare disorders and infectious diseases, is pleased to announce that the Company has retained Pharm-Olam, LLC, with proven clinical experience in infectious diseases ... Read More...
33 views4 min read

MindMed Advances 18-MC, Potential Treatment for Opioid Addiction, Into Further Clinical Testing

Mind Medicine (MindMed)
Company continues research, without interruption, and on schedule NEW YORK, March 25, 2020 -- Mind Medicine (MindMed), Inc. (NEO: MMED; OTC: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, today announced that the company has begun enrollment in further human safety studies of 18-MC, the company's oral... Read More...
5 views4 min read

Champignon Brands Appoints Dr. Joseph Gabriele, Ernst & Young 2018 Health Care Entrepreneur Of The Year And Delivra™ Inventor To Special Advisory Committee

Braxia Scientific
VANCOUVER, British Columbia, March 25, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, continues ... Read More...
1 views4 min read

Revive Therapeutics Appoints Dr. David Boulware, MD, as Scientific Advisor for Infectious Diseases including COVID-19

Revive Therapeutics
TORONTO, March 24, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV), a life sciences company, is pleased to announce that Dr. David Boulware, MD, MPH, CTropMed, FIDSA, will join the Company as a Scientific Advisor to guide on the Company’s current and future clinical programs including its research and development st... Read More...
Joint Venture1 views6 min read

Primo Nutraceuticals Inc., COVID-19 Preparedness and Support commitment to join forces with Celebrity Driven Brand Beauty Kitchen to produce a Hand Sanitizer

Primo Nutraceuticals
VANCOUVER, British Columbia, March 24, 2020 -- PRIMO NUTRACEUTICALS INC. (CSE:PRMO) (BUGVF) (8BV.F) (8BV.F) (8BV.MU) (8BV.SG) ("Primo") is pleased to announce that it has signed a production order with Celebrity Driven Brand Beauty Kitchen to provide a free non-hydroalcoholic gel to local communities after fears of hand sanitizer shortage... Read More...
1 views2 min read

Primo Announces Corporate Update

Primo Nutraceuticals
VANCOUVER, British Columbia, March 23, 2020 -- PRIMO NUTRACEUTICALS INC. (CSE:PRMO) (BUGVF) (8BV.F) (8BV.F) (8BV.MU) (8BV.SG) ("Primo") is pleased to announce that it has satisfied the provisions of the information guidelines of National Policy 12-203, by filing its annual financial statements and MD&A for the year ended July 31, 2019... Read More...
1 views3 min read

Intelgenx To Report Fourth Quarter And Full-year 2019 Financial Results On March 26; Conference Call To Follow On March 27

IntelGenx Technologies
SAINT LAURENT, Quebec, March 23, 2020 -- IntelGenx Corp. (IGX.V) (IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its fourth quarter and full-year 2019 financial results before market open on Thursday, March 26, 2020.As previously announced, the U.S. Food and Drug Administration has assigned a P... Read More...
10 views6 min read

CEO of Champignon Brands Shares Strategic Goals in Exclusive NetworkNewsWire Broadcast

Braxia Scientific
NEW YORK, March 23, 2020 -- via NetworkNewsAudio – Champignon Brands Inc. (SHRM.CN) today announces the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”).The interview can be heard at: http://nnw.fm/S39TuChampignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith in an... Read More...
1 views4 min read

Mota Ventures Launching Immune Support CBD Line; Pure Herbal Immunity Blend Acquiring 1,838 New Customers Within a Week

Thoughtful Brands
VANCOUVER, BC / ACCESSWIRE / March 21, 2020 / Mota Ventures Corp. (MOTA.CN)(FSE:1WZ:GR)(PEMTF) (the "Company" or "Mota") is pleased to announce that since the launch of the Pure Herbal Immunity Blend under the First Class brand on March 14th, 2020, it has had an exceptional reception, acquiring 1,838 new customers.The all-natural Immunity... Read More...
2 views3 min read

Champignon Brands Announces Normal Course Issuer Bid For Common Shares Of The Corporation

Braxia Scientific
VANCOUVER, British Columbia, March 20, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushrooms and novel delivery platforms for the pharmaceutical and nutraceutical industries, is pleased to announce it intends... Read More...
1 views6 min read

Revive Therapeutics Explores the Use of Bucillamine as a Novel Treatment for Infectious Diseases including COVID-19

Revive Therapeutics
TORONTO, March 20, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV), a life sciences company, is pleased to announce that it is exploring the use of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the coronavirus disease (COVID-19). The Company has applied for a pro... Read More...
16 views5 min read

Champignon Brands Expands Alternative Medicine Ip Portfolio With Ketamine, Adaptogenic Delivery Systems/formulations

Braxia Scientific
VANCOUVER, British Columbia, March 19, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushrooms and mushroom-infused products, today introduces new proprietary intellectual property (“IP”) into its vertically in... Read More...
1 views4 min read

Empower Clinics Daily Patient Count Continues at Record Pace with Medical Cannabis Certifications Deemed an Essential Service

Empower Clinics
Empower Clinics adapts operational processes to manage continued record patient counts during COVID-19 outbreakVANCOUVER, BC / ACCESSWIRE / March 18, 2020 / EMPOWER CLINICS INC. (CBDT.CN) (EPWCF) (Frankfurt 8EC) ("Empower" or the "Company"), a vertically integrated and growth-oriented life sciences company, announces that patient visits i... Read More...
1 views4 min read

Core One Labs Signs Definitive Agreements for Previously Announced $1.5M Convertible Debt Facility with Cannabis Growth Opportunity Corporation

Core One Labs
Vancouver, British Columbia--(Newsfile Corp. - March 18, 2020) - Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (FSE: LD61) (WKN: A14XHT) ("COOL") is pleased to announced that, further to its news release dated February 11, 2020, the Company has signed definitive agreements with respect to a CDN$1,500,000 convertible debt facility with C... Read More...
1 views4 min read

Mota Ventures Announces 832% Growth in February 2020 over the Same Period Last Year and Provides Update on First Class CBD Sales

Thoughtful Brands
VANCOUVER, BC / ACCESSWIRE / March 13, 2020 / Mota Ventures Corp. (MOTA.CN)(1WZ1.F)(PEMTF) (the "Company") is excited to announce that for the month of February 2020, its First Class CBD brand achieved sales of Cdn$2,981,000, with related expenses for the same time period totaling Cdn$2,814,000. Due to accelerated marketing efforts in lat... Read More...
LOIM & A1 views5 min read

Roadman Investments Enters Into Letter Of Intent To Acquire Panasia Distribution Corp.

Right Season Investments
VANCOUVER, British Columbia, March 13, 2020 -- Roadman Investments Corp. (LITT.V)(FWB:1QD)(RMANF) (“Roadman Investments” or the “Company”) is pleased to announce that on March 12, 2020 the Company has entered into a Letter of Intent (“LOI”) to acquire 75 per-cent of the issued and outstanding shares of PanAsia Distribution Corp. (“PanAsia... Read More...
M & A1 views4 min read

Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations

Mind Medicine (MindMed)
John Hopkins professor and psychedelics expert Matthew Johnson to act as senior advisor to committeeNEW YORK , March 12, 2020 -- Mind Medicine (MindMed) Inc. ("MindMed") has formed a Technology Evaluation, Acquisition and Scientific Integrity Board Committee to identify and expand the company's clinical trial pipeline and IP portfolio of... Read More...
1 views3 min read

Graph Blockchain Closes First Tranche Of Financing

Graph Blockchain
Graph Blockchain Inc., has closed first tranche of a non-brokered private placementA total of 5,000,000 units were issued at a price of $0.03 per unit for gross proceeds of $150,000TORONTO, March 11, 2020 -- Graph Blockchain Inc. ("Graph" or "Company") (CSE: GBLC) is pleased to announce the closing of a non-brokered private placement fina... Read More...
M & A1 views7 min read

Hollister Biosciences Signs Definitive Agreement to Acquire Venom Extracts With $16.4 Million in Revenue and $2.48 Million EBITDA

Hollister Biosciences
This highly accretive acquisition will strengthen Hollister's brand portfolio and broaden its distribution across multiple statesVANCOUVER, March 6, 2020 - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the "Company" or "Hollister") – a diversified cannabis branding company with products in 220 dispensaries throughout... Read More...
Joint VentureM & A1 views4 min read

Empower Clinics Announces Advancement of Joint Venture with Heritage Cannabis in the United States

Empower Clinics
VANCOUVER, BC / ACCESSWIRE / March 5, 2020 / EMPOWER CLINICS INC. (CBDT.CN) (EPWCF) (Frankfurt 8EC) ("Empower" or the "Company"), a vertically integrated and growth-oriented life sciences company is pleased to announce the advancement of its previously announced Joint Venture Partnership ("JV") with Heritage Cannabis Holdings Corp. (CSE:C... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!